Prepare for your visit
Christopher D Allee
Optometrist · Bellaire, TX · NPI 1154324408
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$7,602.19
in general payments reported to CMS, 2019-2025 · $864 in 2025
The $864 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Who reported paying
General payments only, top 6 by amount.
- Sun Pharmaceutical Industries INC. $1,194.70
- Abbvie INC. $1,018.55
- Alcon Vision LLC $777.09
- Allergan, INC. $608.01
- Novartis Pharmaceuticals Corporation $563.61
- Aerie Pharmaceuticals, INC. $358.75
Drugs and devices associated with these payments
Lumigan Cequa Clareon Alphagan P Vevye Vyzulta Vuity Rxsight Contact Lens Rxsight Injector Handpiece Rxsight Injector Cartridge Light Adjustable Lens (Lal) Rxsight Light Delivery Device (Ldd)
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Christopher Allee listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1079201/christopher-d-allee